Il tuo browser non è aggiornato!

Aggiornalo per vedere questo sito correttamente ed utilizzare tutte le sue funzionalità.

▷ Corsi ECM online, FAD, Residenziali - IkosECM.it | Telefono +39.011.377717

IKOS S.R.L., Via Legnano, 26 Torino

triangle
WEBINAR - NANOSCIENCE IN CANCER IMMUNOTHERAPY

WEBINAR - NANOSCIENCE IN CANCER IMMUNOTHERAPY

Dati principali del Corso ECM WEBINAR

Autorizzazione ministeriale n°
1809 - 315553
Codice evento
C0549
Edizione n°
1
Luogo
Online
Data
dal 09/03/21
al 11/03/21
Ora Inizio
14:30
Ora Fine
18:30
Totale ore formative
10.00
Modalità download certificato
Email / Web
 
Salva questo corso nel tuo Smartphone: QR Code Corso ECM WEBINAR
 
crediti ecm
0
Corso ECM WEBINAR

WEBINAR - NANOSCIENCE IN CANCER IMMUNOTHERAPY

UNITO-POLITO CONFERENCE SERIES IN CANCER

The Nanoscience in Cancer Immunotherapy Workshop (NCIW) is an international meeting jointly organized by the Università and Politecnico of Turin with the aim to provide a platform for discussion on the most recent advances in tumor immunology with a focus on nano bio-technology as a strategy to foster the impact of immunotherapy on cancer treatment.
The main goal of the NCIW is to provide a challenging transdisciplinary environment where life and nano scientists can exchange their knowledge and latest findings in order to accelerate and improve the coordinated progress of oncology, drug development and delivery. The program covers topics from basic research in tumor immunology to the latest advancements in the design of complex tissue models and of nanotechnology based delivery systems in cancer immunotherapy.


SUBSCRIPTION FEE
€ 70,00 iscrizione standard
PHD Students - € 50,00
Students - € 50,00
 
 
Questo è un corso RESIDENZIALE, il corso è chiuso, non è più possibile iscriversi.
  • € 7000 iva inclusa (22%)

    • PHD Students (Free first 100)
    • DOTTORANTI UNITO-POLITO
    • PHD students
    • Students
le iscrizioni sono terminate il 11.03.2021
Moduli del Corso ECM WEBINAR

                                                                   9 March 2021

 

14.30 – 14.45 – SALUTI ISTITUZIONALI

 

14.45 – 14.55 – Introduzione e presentazione dei lavori 

 

 

OPENING LECTURE

14.55 - 15.20 - Haifa SHEN - Methodist Hospital Research Institute Houston- Houston (TX, USA)

Therapeutic Cancer NanoVaccine

 


A ROLE FOR NANOSCIENCE IN CANCER IMMUNOTHERAPY

Chairs: Gloria BERLIER – Valentina CAUDA

 

15.20 - 15.45 - Jen MORTON - Beatson Institute, CRUK Glasgow Center, Glasgow (UK)

Exploring opportunities for immunotherapy in mouse models of pancreatic cancer

 

15.45-16:10 - Cornelis MELIEF - Dep. of Immunohemathology and Blood Transfusion Leiden University Medical Center, Leiden, (NL)

Combination immunotherapy of Cancer involving Therapeutics vaccination

 

16.15 – 16.35 – N. 3 AULE VIRTUALI POSTER

 

16.40 - 16.50 – POSTER VINCITORE 1 

 

16.50 - 17.15 - Anna SCHWENDEMAN  -  University of Michigan Ann Arbor, (USA)

HDL Nanodiscs Discovery and Application for Cancer Immunotherapy   

 
17.15 – 17.40 - Luisa DE COLA - Laboratoire de Chimie et des Biomatériaux Supramoléculaires, Univ. Strasbourg (F)

Nanocarriers for biomolecules delivery

 


“JUST THE WOMAN I AM” KEYNOTE LECTURE

 

17:40 - 18.05 - Elisabetta DEJANA – Department of Immunology, Genetics and Pathology, Uppsala (SE)

Donne e scienza: Il cervello ha genere?

 

 

 




10 March 2021

TUMOR MICROENVIRONMENT AND MODELS

Chairs: Valeria CHIONO – Clara MATTU

 

14.30– 14,55 - David TING - Massachusetts General Hospital - Cancer Center - Boston (MA, USA)

Single Cell Technologies to Define Intratumoral Heterogeneity

 

14.55 - 15.20 - Gabriele BERGERS - VIB-KU Leuven Center for Cancer Biology, Leuven (B)

Creating an Immune-stimulating Tumor Microenvironment: a Vascular Perspective

 

15.20 - 15.45 - Kairbaan HODIVALA-DILKE - Barts Cancer Institute London, London (UK)

New routes for vascular modulation

 

15.45 - 16.10 - Joao MANO – Department of Chemistry - University of Aveiro, Aveiro (Portugal)

Soft biomaterials for engineering 3D cancer models

 

16.10 - 16.35 - Giulia ADRIANI - Singapore Immunology Network (SIgN) Agency for Science, Technology and Research. Singapore

3D microfluidic model of tumor microenvironment for pre-clinical screening of immunotherapies

 

16.40 – 17.00 – N. 3 AULE VIRTUALI POSTER

 

17.05 – 17.15 – POSTER VINCITORE 2


 

CELL-BASED IMMUNOTHERAPY

Chairs: Paola CAPPELLO – Marco Agostino DERIU

 

17.15 – 17.40 - Samuel MOK - University of Texas - MD Anderson Cancer Center, Houston (TX, USA)

Anticancer immunotherapy by MFAP5 blockade suppresses ovarian cancer progression

 

17.40 - 18.05 - Mariolina SALIO - MRC Human Immunology Unit, WIMM, University of Oxford, Oxford (UK)

Harnessing innate-like T cells in cancer immunotherapy

 

18.05 - 18.30 - Michael S. GOLDBERG - Dep. of Cancer Immunology Dana-Farber Cancer Institute, Boston, (MA, USA)

Intraoperative immunotherapy

 

 

 

 

11 March 2021

 

MYELOID CELLS ORCHESTRATE TUMOR RESPONSE

Chair: Federico BUSSOLINO

 

14.30 - 14.55 - Paola ALLAVENA - Humanitas University, Rozzano (I)

Macrophage Reprogramming using TLR-agonist-loaded Polymeric Nanocapsules for the treatment of Cancer

 

14.55 - 15.20 - Dmitry GABRILOVICH - The Winstar Institute, Philadelphia, (PA, USA)

Regulation of tumor microenvironment by myeloid-derived suppressor cells

 

15.20 – 15.30 – POSTER VINCITORE 3

 

15.35 – 15.55 – AULE VIRTUALI POSTER

 

KEYNOTE LECTURE

16.00 – 16.25 - Melody SWARTZ - Pritzker School of Molecular Engineering - University of Chicago (MI, USA)

 

 

EMERGING TECHNOLOGIES IN CANCER IMMUNOLOGY

Chairs: Luca PRIMO – Alberto PULIAFITO

 

16.25 - 17.00 - Massimiliano PAGANI – Istituto Nazionale Genetica Molecolare - Milan (I)

Organoid models to decipher the interplay between tumor and the immune system

 

17.00 – 17.25 - Giovanni CIRIELLO - Université de Lausanne, (CH)

Cancer Evolutionary Dependencies

 

17.25 - 17.50 - Jérome GALON - Laboratory of Integrative Cancer Immunology, Sorbonne Université, Sorbonne Paris (F)

The immune contexture in the era of cancer immunotherapy

 

17.50 - 18.15 - Henner FARIN - Georg-Speyer-Haus - Institute Tumor Biology and Experimental Therapy – Frankfurt (D)
Patient-derived tumor organoids to model stromal interactions and cell-based immunotherapies


Requisiti tecnici per la fruizione del corso

Requisiti tecnici per la fruizione del corso:
• Connessione a Internet
• Browser web di ultima generazione 

Prova di apprendimento

La prova di apprendimento potrà essere effettuata al termine del webinar entro il 14 marzo 2021. 
La prova di apprendimento consisterà in un questionario composto da 45 domande a risposta multipla con 4 possibilità di risposta di cui una sola giusta. 
La soglia di superamento prevista è del 75%. E' prevista una doppia randomizzazione delle domande. 

Conoscenze richieste

CONOSCENZA LINGUA INGLESE

Obiettivi formativi del corso

DOCUMENTAZIONE CLINICA. PERCORSI CLINICO-ASSISTENZIALI DIAGNOSTICI E RIABILITATIVI, PROFILI DI ASSISTENZA - PROFILI DI CURA

globar card ecm a distanza
Acquista la GLOBAL CARD e accedi a tutti i corsi online IKOS fino al 31 dicembre 2023